Deadly Harvest: The Intimate Relationship Between Our Heath and Our Food (70 page)

404
Kuo, F.E., and A.F. Taylor. “A Potential Natural Treatment for Attention-deficit/Hyperactivity Disorder: Evidence from a National Study.”
Am J Public Health
94:9 (2004): 1580–1586.

405
Logan, A.C. “Omega-3 Fatty Acids and Major Depression: A Primer for the Mental Health Professional.”
Lipids Health Dis
3 (2004): 25.

406
Klerman, G.L. “The Current Age of Youthful Melancholia. Evidence for Increase in Depression among Adolescents and Young Adults.”
Br J Psychiatry
152 (1988):
4–14
.

407
Klerman, G.L., and M.M. Weissman. “Increasing Rates of Depression.”
JAMA
261:15 (1989): 2229–2235.

408
Noaghiul, S.F., J.R. Hibbeln, and M.M. Weissman. “Seafood Consumption and Cross-national Prevalence Rates of Bipolar Disorders and Schizophrenia.”
Biol Psychiatr
49:8 Suppl S (2001): 110S.

409
McGrath-Hanna, N.K., D.M.
Greene, R.J. Tavernier, and A. Bult-Ito
. “Diet and Mental Health in the Arctic: Is Diet an Important Risk Factor for Mental Health in Circumpolar Peoples?—A Review.”
Int J Circumpolar Health
62:3 (2003):
228–241
.

410
Tanskanen, A., J.R.
Hibbeln, J. Tuomilehto,
et al. “Fish Consumption and Depressive Symptoms in the General Population in Finland.”
Psychiatr Serv
52:4 (2001):
529–531
.

411
Noaghiul, S.F., J.R. Hibbeln, and M.M. Weissman. “Seafood Consumption and Cross-national Prevalence Rates of Bipolar Disorders and Schizophrenia.”
Biol Psychiatr
49:8 Suppl S (2001): 110S.

412
Maes, M., R.
Smith, A. Christophe A,
et al. “Fatty Acid Composition in Major Depression: Decreased Omega-3 Ratio Fractions in Cholesteryl Esters and Increased C20: 4 Omega-6/C20:5 Omega-3 Ration in Choleseteryl Esters and Phospholipids.”
J Affective Disord
38:1 (1996): 35–46.

- Hibbeln, Joseph, and Norman Salem Jr. “Omega-3 Fatty Acids and Psychiatric Disorders: Current Status of the Field.” In Holick, M.F. (ed.).
Vitamin D: Molecular Biology, Physiology, and Clinical Applications
. Totowa, NJ: Humana Press, 1999.

413
Tolmunen, T., J.
Hintikka, A. Ruusunen,
et al.
“Dietary Folate and the Risk of Depression in Finnish Middle-Aged Men: A Prospective Follow-up Study.”
Psychother Psychosom
73:6 (2004):
334–339
.

- Ramos, M.I., L.H.
Allen, M.N. Haan,
et al.
“Plasma Folate Concentrations are Associated with Depressive Symptoms in Elderly Latina Women Despite Folic Acid Fortification.”
Am J Clin Nutr
80:4 (2004):
1024–1028
.

- Carney, M.W., A.
Ravindran, M.G. Rinsler, and D.G. Williams.
“Thiamine, Riboflavin and Pyridoxine Deficiency in Psychiatric In-Patients.”
Br J Psychiatry
141 (1982):
271–272
.

- Hintikka, J., T.
Tolmunen, A. Tanskanen, and H. Viinamaki.
“High Vitamin B12 Level and Good Treatment Outcome May Be Associated in Major Depressive Disorder.”
BMC Psychiatry
3:1 (2003): 17.

414
Wehr, T.A., W.C.
Duncan Jr, L. Sher, et al.
“A Circadian Signal of Change of Season in Patients with Seasonal Affective Disorder.”
Arch Gen Psychiatry
58:12 (2001): 1108–1114.

415
Lane, A.M., and D.J.
Lovejoy.
“The Effects of Exercise on Mood Changes: The Moderating Effect of Depressed Mood.”
J Sports Med Phys Fitness
41:4 (2001): 539–545.

416
Jablensky,
A., N. Sartorius, G. Ernberg,
et al. “Schizophrenia: Manifestations, Incidence and Course in Different Cultures. A World Health Organization Ten-Country Study.”
Psychol Med Monogr Suppl
20 (1992): 1–97.

417
Barbato, A.
Schizophrenia and Public Health
. Geneva: the World Health Organization, 1998.

418
Puri, B.K., A.J.
Richardson, D.F. Horrobin,
et al. “Eicosapentaenoic Acid Treatment in Schizophrenia Associated with Symptom Remission, Normalisation of Blood Fatty Acids, Reduced Neuronal Membrane Phospholipid Turnover and Structural Brain Changes.”
Int J Clin Pract
54:1 (2000):
57–63
.

419
Peet, M. “Eicosapentaenoic Acid in the Treatment of Schizophrenia and Depression: Rationale and Preliminary Double-Blind Clinical Trial Results.”
Prostaglandins Leukot Essent Fatty Acids
69:6 (2003):
477–485
. Peet, M., J.
Brind, C.N. Ramchand,
et al. “Two Double-Blind Placebo-Controlled Pilot Studies of Eicosapentaenoic Acid in the Treatment of Schizophrenia.”
Schizophr Res
49:3 (2001):
243–251
.

420
Christensen, O., and E. Christensen. “Fat Consumption and Schizophrenia.”
Acta Psychiatr Scand
78:5 (1988):
587–591
.

421
Peet, M. “International Variations in the Outcome of Schizophrenia and the Prevalence of Depression in Relation to National Dietary Practices: An Ecological Analysis.”
Br J Psychiatry
184 (2004): 404–408.

422
Eaton, W., P.B.
Mortensen, E. Agerbo,
et al.
“Coeliac Disease and Schizophrenia: Population-based Case-control Study with Linkage of Danish National Registers.”
Br Med J
328:7437 (2004):
438–439
. Lorenz, K. “Cereals and Schizophrenia.”
Adv Cereal Sci Technol
10 (1990): 435–469.

423
Lorenz, K. “Cereals and Schizophrenia.”
Adv Cereal Sci Technol
10 (1990): 435–469.

424
Peet, M. “International Variations in the Outcome of Schizophrenia and the Prevalence of Depression in Relation to National Dietary Practices: An Ecological Analysis.”
Br J Psychiatry
184 (2004):
404–408
.

425
Dohan, F.C., and J.C.
Grasberger.
“Relapsed Schizophrenics: Early Discharge from the Hospital after Cereal-free, Milk-free Diet.”
Am J Psychiatry
130:6 (1973): 658–688.

426
Chen, H., S.M.
Zhang, M.A. Hernan,
et al. “Diet and Parkinson’s Disease: A Potential Role of Dairy Products in Men.”
Ann Neurol
52:6 (2002): 793–801.

427
Park, M. “Consumption of Milk and Calcium in Midlife and the Future Risk of Parkinson Disease.”
Neurology
64:6 (2005): 1047–1051.

428
Duan, W., B.
Ladenheim, R.G. Cutler, et al.
“Dietary Folate Deficiency and Elevated Homocysteine Levels Endanger Dopaminergic Neurons in Models of Parkinson’s Disease.”
J Neurochem
80:1 (2002): 101–110.

429
Abbott, R.D., H.
Petrovitch, L.R. White, et al.
“Frequency of Bowel Movements and the Future Risk of Parkinson’s Disease.”
Neurology
57:3 (2001): 456–462.

430
McCarty, M.F. “Does a Vegan Diet Reduce Risk for Parkinson’s Disease?”
Med Hypotheses
57:3 (2001): 318–323.

Johnson, C.C., J.M.
Gorell, B.A. Rybicki, et al.
“Adult Nutrient Intake as a Risk Factor for Parkinson’s Disease.”
Intl J Epidemiol
28:6 (1999): 1102–1109.

431
Ross, G.W., R.D.
Abbott, H. Petrovitch, et al.
“Association of Coffee and Caffeine Intake with the Risk of Parkinson Disease.”
JAMA
283:20 (2000): 2674–2679.

432
Kniker, T. “Dietary Changes Improve Autistic Symptoms in Some Patients.” 12th International Conference on Autism, Durham University, April 5, 2001.

433
Sun, Z. “Beta-casomorphin Induces Fos-like Immunoreactivity in Discrete Brain Regions Relevant to Schizophrenia and Autism.”
Autism
3 (1999): 67–83.

434
Sun, Z. “A Peptide Found in Schizophrenia and Autism Causes Behavioral Changes in Rats.”
Autism
3 (1999): 85–95.

- Kniker, T. “Dietary Changes Improve Autistic Symptoms in Some Patients.” 12th International Conference on Autism, Durham University, April 5, 2001.

435
Dunne, C. “Adaptation of Bacteria to the Intestinal Niche: Probiotics and Gut Disorder.”
Inflamm Bowel Dis
7:2 (2001): 136–145.

436
Knickmeyer, R., S.
Baron-Cohen, P. Raggatt, and K. Taylor.
“Foetal Testosterone, Social Relationships, and Restricted Interests in Children.”
J Child Psychol Psychiatry
46:2 (2005): 198–210.

- Baron-Cohen, S., R.C.
Knickmeyer, and M.K. Belmonte.
“Sex Differences in the Brain: Implications for Explaining Autism.”
Science
310:5749 (2005): 819–823.

437
Konturek, P.C., J.W.
Konturek, M. Czesnikiewicz-Guzik, et al.
“Neuro-hormonal Control of Food Intake: Basic Mechanisms and Clinical Implications.”
J Physiol Pharmacol
56:Suppl 6 (2005): 5–25.

438
le Roux, C.W., M.
Patterson, R.P. Vincent, et al.
“Postprandial Plasma Ghrelin is Suppressed Proportional to Meal Calorie Content in Normal-weight but Not Obese Subjects.”
J Clin Endocrinol Metab
90:2 (2005): 1068–1071.

439
Flier, J.S., and J.K.
Elmquist.
“A Good Night’s Sleep: Future Antidote to the Obesity Epidemic?”
Ann Intern Med
141:11 (2004): 885–886.